[go: up one dir, main page]

EA201301341A1 - PHARMACEUTICAL COMPOSITION, POSSESSING PANCREOTOPROTECTIVE ACTION, ITS APPLICATION FOR PREVENTION OR TREATMENT OF PANCREATITIS AND METHOD OF PREVENTION AND TREATMENT OF PANCREATITIS - Google Patents

PHARMACEUTICAL COMPOSITION, POSSESSING PANCREOTOPROTECTIVE ACTION, ITS APPLICATION FOR PREVENTION OR TREATMENT OF PANCREATITIS AND METHOD OF PREVENTION AND TREATMENT OF PANCREATITIS

Info

Publication number
EA201301341A1
EA201301341A1 EA201301341A EA201301341A EA201301341A1 EA 201301341 A1 EA201301341 A1 EA 201301341A1 EA 201301341 A EA201301341 A EA 201301341A EA 201301341 A EA201301341 A EA 201301341A EA 201301341 A1 EA201301341 A1 EA 201301341A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pancreatitis
prevention
treatment
pharmaceutical composition
glu
Prior art date
Application number
EA201301341A
Other languages
Russian (ru)
Other versions
EA023136B1 (en
Inventor
Петр Александрович Белый
Евгений Александрович ЧЕРТОРИЖСКИЙ
Михаил Владимирович ОВЧИННИКОВ
Original Assignee
Замертон Холдингс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Замертон Холдингс Лимитед filed Critical Замертон Холдингс Лимитед
Priority to EA201301341A priority Critical patent/EA023136B1/en
Publication of EA201301341A1 publication Critical patent/EA201301341A1/en
Publication of EA023136B1 publication Critical patent/EA023136B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к медицине и касается фармацевтической композиции, содержащей пептиды Asp-Glu-Gly, Lys-Asp-Glu, Ala-Asp-Glu-Leu. Композиция обладает выраженным панкреопротекторным действием, что позволяет использовать фармацевтическую композицию, содержащую пептиды Asp-Glu-Gly, Lys-Asp-Glu, Ala-Asp-Glu-Leu для профилактики или лечения панкреатита.The invention relates to medicine and relates to a pharmaceutical composition comprising peptides Asp-Glu-Gly, Lys-Asp-Glu, Ala-Asp-Glu-Leu. The composition has a pronounced pancreatic action that allows the use of a pharmaceutical composition containing peptides Asp-Glu-Gly, Lys-Asp-Glu, Ala-Asp-Glu-Leu for the prevention or treatment of pancreatitis.

EA201301341A 2013-12-26 2013-12-26 Pharmaceutical composition possessing pancreoprotective activity, use thereof for prevention and/or treatment of pancreatitis and method for prevention and treatment of pancreatitis EA023136B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201301341A EA023136B1 (en) 2013-12-26 2013-12-26 Pharmaceutical composition possessing pancreoprotective activity, use thereof for prevention and/or treatment of pancreatitis and method for prevention and treatment of pancreatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201301341A EA023136B1 (en) 2013-12-26 2013-12-26 Pharmaceutical composition possessing pancreoprotective activity, use thereof for prevention and/or treatment of pancreatitis and method for prevention and treatment of pancreatitis

Publications (2)

Publication Number Publication Date
EA201301341A1 true EA201301341A1 (en) 2015-06-30
EA023136B1 EA023136B1 (en) 2016-04-29

Family

ID=53488010

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301341A EA023136B1 (en) 2013-12-26 2013-12-26 Pharmaceutical composition possessing pancreoprotective activity, use thereof for prevention and/or treatment of pancreatitis and method for prevention and treatment of pancreatitis

Country Status (1)

Country Link
EA (1) EA023136B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2341282C2 (en) * 2007-01-24 2008-12-20 Общество с ограниченной ответственностью "БИОН" Pharmaceutical composition of pancreatropic activity and method of pharmaceutical composition production
RU2482128C1 (en) * 2011-12-28 2013-05-20 Замертон Холдингс Лимитед Peptides possessing cytoprotective activity

Also Published As

Publication number Publication date
EA023136B1 (en) 2016-04-29

Similar Documents

Publication Publication Date Title
CR20160582A (en) COMPOSITION TO TREAT DIABETES, CONTAINING A PROLONGED ACTION INSULIN ANALOG AND A PROLONGED ACTION INSULINOTROPIC PEPTIDE CONJUGATE
EA033325B1 (en) Bromodomain inhibitors
MX378273B (en) ACTIVE COMPOUNDS TOWARDS BROMODOMAINS.
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
PH12016501441A1 (en) Chimeric alkaline phosphate-like proteins
EA201690159A1 (en) METHODS AND COMPOSITIONS FOR CANCER TREATMENT
EA201790575A1 (en) TRIAZOLOPIRASINONS AS PDE1 INHIBITORS
MX2016011810A (en) Pharmaceutical compositions of therapeutically active compounds.
EA201691481A1 (en) C5a inhibitors for the treatment of viral pneumonia
EA201792157A1 (en) IMIDAZOPIRASINONS AS PDE1 INHIBITORS
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
EA201692007A1 (en) IZOINDOLINON COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA, AND RELATED DISORDERS
MX376200B (en) NASAL POWDER FORMULATION FOR THE TREATMENT OF HYPOGLYCEMIA.
EA201692008A1 (en) SUBSTITUTED CONDENSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
EA201791454A1 (en) DRUG FORMS FOR TRANSDERMAL ADMINISTRATION
MX2019001634A (en) AMIDAS COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF THESE AND METHODS TO USE THEM.
EA201690783A1 (en) SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES
EA201792262A1 (en) PIROGLUTAMAT VORTIOKSETINA
EA201691108A1 (en) Quinazoline-THF-Amines as PDE1 Inhibitors
EA201691773A1 (en) HALOGENATED HINAZOLIN-THF-AMINES AS PDE1 INHIBITORS
EA201691335A1 (en) HEXAHYDROFUROPYRROLES AS INHIBITORS PDE1
PH12018550008A1 (en) Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
CR20160353A (en) CHOLESTERILE ESTER TRANSFER PROTEIN INHIBITOR (CETP) AND PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
PL3203998T3 (en) SUBSTITUTE AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES
MA40642A (en) Novel peptide derivatives and uses thereof

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ RU

NF4A Restoration of lapsed right to a eurasian patent

Designated state(s): AM AZ BY KZ RU

PC4A Registration of transfer of a eurasian patent by assignment